What You Should Know:
- A new data analysis from DoseSpot, a leader in e-prescribing and healthcare technology solutions, found that 92 percent of GLP-1 prescriptions the company processed in Q1 2025 could have been filled at a lower price. This translates to a staggering $10.2M in missed savings for patients on these popular medications.
- The analysis of over 100,000 prescriptions highlights a significant gap in cost transparency and access to savings programs, contributing to the
Read More
Clearsense and Nordic to Deliver End-to-End Application Portfolio Management Solution
What You Should Know:
- Clearsense®, a cloud-based data enablement platform company, and Nordic®, a global healthcare consulting firm announced a strategic collaboration to offer the industry’s only end-to-end solution for Application Portfolio Management (APM).
- The partnership is designed to help health systems assess, prioritize, and eliminate redundant or outdated software applications, unlocking immediate savings and modernizing their IT infrastructure.
Addressing the Challenge
Read More
Diabetes-Related Healthcare Costs Have Plateaued, Marking a Rare Opportunity for Employers, Nomi Health Report Finds
What You Should Know:
- After decades of relentless increases, diabetes-related healthcare costs have finally plateaued, according to a new analysis by Nomi Health. The key finding from the company's latest "Trends in Spend" report marks a rare moment of opportunity for self-funded employers to re-evaluate how they manage one of their highest-cost conditions before the next wave of expenses hits.
- Analyzing employer-sponsored claims data from 2021–2024, Nomi Health found that while
Read More
Tandem’s t:slim X2 Insulin Pump Now Integrates with Abbott’s FreeStyle Libre 3 Plus Sensor
What You Should Know:
- Tandem Diabetes Care, an insulin delivery and diabetes technology company, today announced that its Tandem t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology now works with Abbott’s FreeStyle Libre® 3 Plus continuous glucose monitoring (CGM) sensor.
- The company has initiated an early access program in the United States and intends to scale availability in the second half of 2025.
Expanding Patient Choice and
Read More
Cylinder’s Virtual Digestive Health Program Reduces Absenteeism by 17% in Older Workers
What You Should Know:
- Cylinder, the leading virtual digestive health provider, today announced new findings demonstrating a 17% reduction in absenteeism among employees aged 50 and older who used its virtual digestive health platform. The results, published in the Journal of Occupational and Environmental Medicine, underscore Cylinder’s significant impact on workforce productivity and healthcare cost savings, particularly for older working adults with chronic gastrointestinal (GI)
Read More
GE HealthCare and Stanford Medicine Renew Research Collaboration to Advance Total Body PET/CT Technology
What You Should Know:
- GE HealthCare has renewed its research collaboration with Stanford Medicine. A key intention of this renewed effort is the development and research of innovative total body PET/CT technology, aiming to explore new clinical pathways and enhance patient outcomes through advanced imaging solutions.
- The collaboration brings together the engineering expertise of GE HealthCare with the clinical and research leadership of Stanford Medicine to push the boundaries of
Read More
Rimidi Partners with Quest Health to Improve Blood Glucose for Diabetes Patients via RPM
What You Should Know:
- Quest Health Solutions, a national leader in diabetes care, today announced compelling results from its Remote Patient Monitoring (RPM) program, developed in partnership with the digital health company Rimidi. In just two months, the Quest Health RPM Services—powered by Rimidi's EHR-integrated platform—led to an 11% improvement in average blood glucose readings among participating patients.
- The collaboration highlights the power of combining
Read More
Glytec Secures $36M to Advance AI-Powered Diabetes Care and Inpatient Glycemic Management
What You Should Know:
- Glytec, a provider of an AI-powered technology platform for diabetes and related conditions, secures a $36M growth investment led by Savitr Capital and Hayfin Capital Management.
- The funding will fuel the continued expansion of Glytec’s platform, including its flagship Glucommander® SaaS solution, and accelerate the development of innovative new technologies. The investment comes as healthcare systems face increasing pressure to improve inpatient
Read More
Artera Launches Real-World Registry to Track AI’s Impact in Cancer Care
What You Should Know:
- Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the launch of its DIRECT-AI registry study. This new study will assess how the ArteraAI Prostate Test influences treatment decision-making between clinicians and patients with localized prostate cancer.
- The study will also monitor participants to evaluate their long-term cancer outcomes, reinforcing Artera's commitment to advancing
Read More
Omada Health Data Shows Companion Program Significantly Boosts GLP-1 Medication Persistence
What You Should Know:
- Omada Health, the virtual between-visit healthcare provider released new data demonstrating that its GLP-1 companion program significantly improves persistence rates for GLP-1 medications.
- The analysis found that members in Omada's program achieved weight loss results similar to those seen in controlled research settings, underscoring the importance of comprehensive support for individuals on these transformative medications.
- The findings provide
Read More
